Skip to main content
Caplight Logo









Astraveus

Astraveus

Private
ParisHealthcare & Life Scienceshttps://www.astraveus.com/

Last Round

Grant

Dec 19, 2024

Total Funding Raised

$36.72M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Astraveus is a biotechnology company that develops the Lakhesys™ platform, a benchtop cell factory for the automated and miniaturized manufacturing of cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts

AI Layer

Non-AI

Keywords

CGT manufacturingmicrofluidic manufacturingcell therapy automationcell and gene therapybenchtop cell factorymicrofluidicssingle-use bioprocessorsfactory-in-a-boxCAR-T manufacturingbioprocessingbiotech equipmentGMPgood manufacturing practiceCDMOcontract development and manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Astraveus Comparables

Compare Astraveus with similar companies based on industry and business-model similarity.

Astraveus comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ori Biotech
89%
Limula
86%
Adva Biotechnology
85%

Astraveus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 19, 2024
GrantOct 24, 2023
SeedJun 27, 2023

Key People

Founding team and executive leadership

Ken Kotz

Chief Technology Officer

Executive Team

Didier Masson

Chief Operating Officer

Executive Team

Astraveus Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 1060% MoM, reaching 1.9K.

  • Jul 20, 2026

    Open roles increased to 31, 2.3x the trailing average.

Astraveus Filings

Explore SEC and related filing metadata, where available.

Astraveus filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Astraveus's valuation, stock price, and market status.

Is Astraveus a public or private company?

Astraveus is a private company.

What is the current stock price of Astraveus?

Astraveus is a private company with no public stock price. No recent secondary market data is available.

How much is Astraveus worth (valuation)?

Valuation information for Astraveus is not publicly available.

Can I buy Astraveus stock?

Astraveus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Astraveus's last funding round?

Astraveus's most recent funding round was Grant on December 19, 2024.

Who are the main investors in Astraveus?

Key investors in Astraveus include AdBio partners.

Will Astraveus IPO soon?

No public IPO plans have been announced for Astraveus.

How can I track Astraveus secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Astraveus's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range55
Year Founded2016
Last FundingDec 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?